verapamil has been researched along with rg7388 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berry, P; Chen, L; Del Bello, F; Halliday, GC; Lunec, J; Middleton, SA; Newell, DR; Nichols, GL; Piergentili, A; Rousseau, RF; Tweddle, DA; Zhao, Y | 1 |
1 other study(ies) available for verapamil and rg7388
Article | Year |
---|---|
Structurally diverse MDM2-p53 antagonists act as modulators of MDR-1 function in neuroblastoma.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cisplatin; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Imidazoles; Indoles; Inhibitory Concentration 50; Neuroblastoma; para-Aminobenzoates; Piperazines; Proto-Oncogene Proteins c-mdm2; Pyrrolidines; Spiro Compounds; Tumor Suppressor Protein p53; Verapamil; Vincristine | 2014 |